A Study to Evaluate XTR006 in Chinese Volunteers

Clinical trial NCT06151795 · COMPLETED

Trial details

NCT number: NCT06151795
Sponsor: Sinotau Pharmaceutical Group
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Alzheimer Disease

Start date: 2023-06-12
Primary completion: 2023-09-27
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.